Global Specific Cancer Immunotherapy Drugs Market Professional Survey Report Forecast 2017-2021

May 2017 | 134 pages | ID: G7E3A2C2839EN
S&P Consulting

Abstracts

This report studies Specific Cancer Immunotherapy Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Amgen
Roche
Bristol Myers Squibb
Dendreon (Valeant)
Novartis
Seattle Genetics
Hangzhou Jinjiang Group
company 8
company 9

By types, the market can be split into

Tablet
Injection
Type 3

By Application, the market can be split into

Leukemia Treatment
Colorectal Cancer Treatment
Other Cancer Treatment

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India

Contents

Global Specific Cancer Immunotherapy Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS

1.1 Definition and Specifications of Specific Cancer Immunotherapy Drugs
  1.1.1 Definition of Specific Cancer Immunotherapy Drugs
  1.1.2 Specifications of Specific Cancer Immunotherapy Drugs
1.2 Classification of Specific Cancer Immunotherapy Drugs
  1.2.1 Tablet
  1.2.2 Injection
  1.2.3 Type
1.3 Applications of Specific Cancer Immunotherapy Drugs
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Specific Cancer Immunotherapy Drugs
2.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
2.4 Industry Chain Structure of Specific Cancer Immunotherapy Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS

3.1 Capacity and Commercial Production Date of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016

4 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Specific Cancer Immunotherapy Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Specific Cancer Immunotherapy Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Specific Cancer Immunotherapy Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Specific Cancer Immunotherapy Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Specific Cancer Immunotherapy Drugs Sales Price
  4.4.2 2016 Specific Cancer Immunotherapy Drugs Sales Price Analysis (Company Segment)

5 SPECIFIC CANCER IMMUNOTHERAPY DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Specific Cancer Immunotherapy Drugs Market Analysis
  5.1.1 North America Specific Cancer Immunotherapy Drugs Market Overview
  5.1.2 North America 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.1.4 North America 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis
5.2 China Specific Cancer Immunotherapy Drugs Market Analysis
  5.2.1 China Specific Cancer Immunotherapy Drugs Market Overview
  5.2.2 China 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.2.4 China 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis
5.3 Europe Specific Cancer Immunotherapy Drugs Market Analysis
  5.3.1 Europe Specific Cancer Immunotherapy Drugs Market Overview
  5.3.2 Europe 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.3.4 Europe 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis
5.4 Southeast Asia Specific Cancer Immunotherapy Drugs Market Analysis
  5.4.1 Southeast Asia Specific Cancer Immunotherapy Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis
5.5 Japan Specific Cancer Immunotherapy Drugs Market Analysis
  5.5.1 Japan Specific Cancer Immunotherapy Drugs Market Overview
  5.5.2 Japan 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.5.4 Japan 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis
5.6 India Specific Cancer Immunotherapy Drugs Market Analysis
  5.6.1 India Specific Cancer Immunotherapy Drugs Market Overview
  5.6.2 India 2012-2017 Specific Cancer Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price Analysis
  5.6.4 India 2016 Specific Cancer Immunotherapy Drugs Market Share Analysis

6 GLOBAL 2012-2017 SPECIFIC CANCER IMMUNOTHERAPY DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Specific Cancer Immunotherapy Drugs Sales by Type
6.2 Different Types of Specific Cancer Immunotherapy Drugs Product Interview Price Analysis
6.3 Different Types of Specific Cancer Immunotherapy Drugs Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis
  6.3.5 Other of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017 SPECIFIC CANCER IMMUNOTHERAPY DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Specific Cancer Immunotherapy Drugs Consumption by Application
7.2 Different Application of Specific Cancer Immunotherapy Drugs Product Interview Price Analysis
7.3 Different Application of Specific Cancer Immunotherapy Drugs Product Driving Factors Analysis
  7.3.1 Office Use of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis
  7.3.2 Personal Use of Specific Cancer Immunotherapy Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS

8.1 Amgen
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Roche
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Bristol Myers Squibb
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Dendreon (Valeant)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Novartis
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Seattle Genetics
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Hangzhou Jinjiang Group
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 company
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

9 DEVELOPMENT TREND OF ANALYSIS OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET

9.1 Global Specific Cancer Immunotherapy Drugs Market Trend Analysis
  9.1.1 Global 2017-2021 Specific Cancer Immunotherapy Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2021 Specific Cancer Immunotherapy Drugs Sales Price Forecast
9.2 Specific Cancer Immunotherapy Drugs Regional Market Trend
  9.2.1 North America 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
  9.2.2 China 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
  9.2.3 Europe 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
  9.2.5 Japan 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
  9.2.6 India 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Forecast
9.3 Specific Cancer Immunotherapy Drugs Market Trend (Product Type)
9.4 Specific Cancer Immunotherapy Drugs Market Trend (Application)

10 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKETING TYPE ANALYSIS

10.1 Specific Cancer Immunotherapy Drugs Regional Marketing Type Analysis
10.2 Specific Cancer Immunotherapy Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Specific Cancer Immunotherapy Drugs by Regions
10.4 Specific Cancer Immunotherapy Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF SPECIFIC CANCER IMMUNOTHERAPY DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Specific Cancer Immunotherapy Drugs
Table Product Specifications of Specific Cancer Immunotherapy Drugs
Table Classification of Specific Cancer Immunotherapy Drugs
Figure Global Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2016
Table Applications of Specific Cancer Immunotherapy Drugs
Figure Global Consumption Volume Market Share of Specific Cancer Immunotherapy Drugs by Application in 2016
Figure Market Share of Specific Cancer Immunotherapy Drugs by Regions
Figure North America Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Figure China Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Figure Europe Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Figure Japan Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Figure India Specific Cancer Immunotherapy Drugs Market Size (2011-2021)
Table Specific Cancer Immunotherapy Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Specific Cancer Immunotherapy Drugs in 2016
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Industry Chain Structure of Specific Cancer Immunotherapy Drugs
Table Capacity and Commercial Production Date of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Specific Cancer Immunotherapy Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Specific Cancer Immunotherapy Drugs 2012-2017
Figure Global 2012-2017 Specific Cancer Immunotherapy Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Specific Cancer Immunotherapy Drugs Market Size (Value) and Growth Rate
Table 2012-2017 Global Specific Cancer Immunotherapy Drugs Capacity and Growth Rate
Table 2016 Global Specific Cancer Immunotherapy Drugs Capacity List (Company Segment)
Table 2012-2017 Global Specific Cancer Immunotherapy Drugs Sales and Growth Rate
Table 2016 Global Specific Cancer Immunotherapy Drugs Sales List (Company Segment)
Table 2012-2017 Global Specific Cancer Immunotherapy Drugs Sales Price
Table 2016 Global Specific Cancer Immunotherapy Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure North America 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure North America 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure China 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure China 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure Europe 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure Europe 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure Southeast Asia 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure Southeast Asia 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure Japan 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure Japan 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Specific Cancer Immunotherapy Drugs 2012-2017
Figure India 2012-2017 Specific Cancer Immunotherapy Drugs Sales Price
Figure India 2016 Specific Cancer Immunotherapy Drugs Sales Market Share
Table Global 2012-2017 Specific Cancer Immunotherapy Drugs Sales by Type
Table Different Types Specific Cancer Immunotherapy Drugs Product Interview Price
Table Global 2012-2017 Specific Cancer Immunotherapy Drugs Sales by Application
Table Different Application Specific Cancer Immunotherapy Drugs Product Interview Price
Table Amgen Basic Information List
Table Amgen Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Seattle Genetics Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Hangzhou Jinjiang Group Basic Information List
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Figure Global 2017-2021 Specific Cancer Immunotherapy Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Specific Cancer Immunotherapy Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Specific Cancer Immunotherapy Drugs Sales Price Forecast
Figure North America 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Specific Cancer Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Specific Cancer Immunotherapy Drugs by Types 2017-2021
Table Global Consumption Volume of Specific Cancer Immunotherapy Drugs by Applications 2017-2021
Table Traders or Distributors with Contact Information of Specific Cancer Immunotherapy Drugs by Regions

COMPANIES MENTIONED

Amgen, Roche, Bristol Myers Squibb, Dendreon (Valeant), Novartis, Seattle Genetics, Hangzhou Jinjiang Group